The EU Commission investigates the merger between two pharmaceutical companies (Illumina / GRAIL)

European Commission to investigate acquisition of pharmaceutical firm GRAIL by biotech firm Illumina* The European Commission will investigate the acquisition of US pharmaceutical company GRAIL by US biotechnology company Illumina. Various European countries, including the Netherlands, support France’s request to the European Commission to investigate this acquisition. Illumina and GRAIL manufacture, among other products, products for tests for detecting cancer at a very early

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Dutch Competition Authority, The EU Commission investigates the merger between two pharmaceutical companies (Illumina / GRAIL), 20 April 2021, e-Competitions April 2021, Art. N° 100482

Visites 169

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues